BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.53% | 59.12% | 52.69% | 41.71% | 28.45% |
| Total Depreciation and Amortization | 11.12% | -5.35% | -20.60% | -7.92% | -13.56% |
| Total Amortization of Deferred Charges | 75.18% | -87.08% | -87.13% | -86.79% | -86.86% |
| Total Other Non-Cash Items | -102.08% | -82.08% | -56.88% | -14.41% | 0.75% |
| Change in Net Operating Assets | 933.49% | -225.53% | 716.83% | 388.08% | 72.05% |
| Cash from Operations | 23.18% | 5.56% | 53.26% | 76.69% | 39.10% |
| Capital Expenditure | -1,210.00% | 52.75% | 95.10% | 96.26% | 98.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,210.00% | 81.60% | 97.89% | 98.09% | 99.86% |
| Total Debt Issued | -- | -0.10% | -0.10% | -- | -- |
| Total Debt Repaid | 60.65% | -757.66% | -1,007.10% | -1,128.51% | -1,395.36% |
| Issuance of Common Stock | -55.55% | 44,451.08% | 30,733.81% | 10,892.07% | 10,888.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 69.00% | -2,249.68% | -1,088.30% | -1,088.30% | -1,064.36% |
| Cash from Financing | 97.21% | 200.18% | 85.98% | -24.35% | -24.68% |
| Foreign Exchange rate Adjustments | -88.86% | 163.23% | 433.74% | 271.53% | 346.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.53% | 160.55% | 116.06% | 99.37% | 58.50% |